Equity Research

Capital ideas from the industry’s brightest minds.

Our award-winning equity research analysts deliver superior investment ideas and value-added perspective for over 650 companies, across seven growth-oriented sectors: consumer; energy and power technologies; financial services and technology; industrials; global services; healthcare; and technology, media, and communications. William Blair’s research universe is diversified across multiple industry verticals and a wide range of market capitalization, with an emphasis on quality business models in their emerging growth phase of development.

650+

companies under
research coverage
70%+

of coverage dedicated to small- and mid-cap growth companies
100+

analysts and research
professionals

As of September 30, 2025

William Blair analysts seek to cover only companies that have above-average growth prospects and above-average quality. They use multiple factors to identify high-quality companies with attractive growth prospects, including the company’s product line, level of service, and management experience.

Our clients include:

Mutual Funds
Investment Advisory Firms
Banks
Pension Funds
Insurance Companies
Money Managers Across North America, Europe, and Asia

Through exhaustive fundamental research and unique insight derived from independent thinking, our award-winning analysts work tirelessly to identify companies that can deliver superior investment returns for our clients.

Recent News

Thursday, December 18, 2025

Sotera Health Company: Initiation of Research Coverage

William Blair initiated research coverage of Sotera Health Company (SHC $16.70), a leading global provider of sterilization solutions, lab testing, and advisory services for the healthcare industry.
Read more
Monday, December 15, 2025

TheRealReal, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of TheRealReal, Inc. (REAL $14.26), an online marketplace for consigned luxury goods.
Read more
Friday, December 12, 2025

Aardvark Therapeutics, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
Read more

See more news

William Blair Thinking Podcast

Navigating the current market environment demands the right informational resource. That is why we launched the William Blair Thinking Podcast, which aims to provide in-depth expertise on today's financial and economic landscape.

What's different about this platform?
It's our most timely and best ideas—the ethos, if you will, of our firm's intellectual capital. All in 20 minutes.
Our latest podcasts
William Blair Shines in 2024 Coalition Greenwich Study with 12 No. 1 Rankings

William Blair, the premier global partnership with expertise in investment banking, investment management, and private wealth management, is thrilled to announce its performance in the annual Coalition Greenwich Voice of the Client – 2024 North American Equity Investors Study.
Learn more

Featured Insights

Friday, December 19, 2025

Economics Weekly: The Supreme Court on IEEPA – What Changes, What Doesn’t

In this Economics Weekly, Richard de Chazal considers the possible outcomes of a Supreme Court ruling and what they could mean for trade policy.
Read more
Friday, December 19, 2025

Monthly Macro: 2026 Economic Outlook

William Blair macro analyst Richard de Chazal discusses why 2026 looks brighter for the economy, exploring the impact of AI-driven investment, evolving policy risks, and the surprising strength of the American consumer.
Listen to the podcast
Friday, December 19, 2025

AI’s Infrastructure Boom: Opportunities and Challenges for Investors

From surging data center construction to the race for advanced microchips, learn why trillions of dollars are pouring into AI and what it means for the future of energy, manufacturing, and investors seeking new opportunities.
Read more